Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CART-33 CAR-T therapy targeting CD33 in relapsed or chemotherapy-refractory acute myeloid leukemia; the trial includes Phase 1 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CART-33 (CAR-T cell therapy targeting CD33)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Relapsed Adult Myeloid Leukemia, Chemotherapy Refractory Adult Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN